Navigation Links
VYVANSE provided behavior, inattention and math test score improvements in children with ADHD
Date:10/29/2008

bility, upper abdominal pain, and affect lability.

VYVANSE, which was introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, was approved in April 2008 to treat ADHD in adults. VYVANSE is now available in six dosage strengths of 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. To date, more than 3 million VYVANSE prescriptions have been filled.

VYVANSE is a therapeutically inactive prodrug, in which d-amphetamine is covalently bonded to l-lysine, and after oral ingestion it is converted to pharmacologically active d-amphetamine. The conversion of VYVANSE to d-amphetamine is not affected by gastrointestinal pH and is unlikely to be affected by alterations in GI transit times.


'/>"/>

Contact: Jacelyn Seng
212-601-8385
Porter Novelli
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Phase III pivotal results presented of VYVANSE to treat ADHD in adults
2. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
3. FDA approves additional dosage strengths of Vyvanse
4. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
5. VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment
6. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
7. All Pets With Cancer in U.S. Provided Free Consultation
8. NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources
9. New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan
10. Score Big With One-of-a-Kind Swarovski Encrusted SCRABBLE(R) Board
11. Local Experts Help Women Living and Working with Cancer Even the Score

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...
(Date:12/1/2009)...EANS, Dec. 1 The Americ...l High School Student Symposium at the New Orleans...T. The symposium, which encourages an interest in ...esearch, is held in conjunction with the Society,s...e the opportunity to explore research on sickle ce...
(Date:12/1/2009)... Dec. 1 With employee be...ber of employers are providing self-service decisi...season, according to a new survey by Watson Wyatt,...mployers who offer these tools believe they lead e...,, According to the survey, 45 percent of compa...
(Date:12/1/2009)...NS, Dec. 1 The American...professional association of blood specialists, exp...nual Meeting from December 5-8, 2009, at the Ernes...The meeting will showcase the latest research and ...leasure to host ASH,s 51st annual meeting, where w...
(Date:12/1/2009)..., Dec. 1 The government of Mexico ...enter for biomedical and nanomedical research, cal...research and development will be integrated with t...op Spanish speaking university in the world. The ...in 2010, has been designed by the internationally-...
Breaking Medicine News(10 mins):Health News:National HIV Non-Profit Announces New Name 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:Mexico City to Build World-Class Hub for Medical Research 2
...of its pioneering stem cell program, the Universit...4.9 million grant from the California Institute fo...uction of a regenerative medicine building on its ...F receiving a portion of funding from CIRM. The re...
...ama at Birmingham (UAB) this month became the firs...adiation therapy. The new technique can turn a 20-...on for selected patients. , Additionally, the new...g to doctors at the UAB Comprehensive Cancer Cente...
...PHILADELPHIA, May 7 Kappa Alpha Psi Fraternity, I...oing partnership with the St.,Jude Children,s Rese...n,children. The celebration will be held at the St...sponsibility of sponsoring events at the local lev...
...CNO ),today reported results for the first quarter...with an increase of 10.7% over,the same period las...cluded,an 11% increase at Bankers Life and a 22% i...21%, but specified disease,products, CIG,s highest...
..., study finds, , , WEDNESDAY, May 7 (Healt...uring pregnancy face an increased risk of complica... meet the criteria for gestational diabetes. , In...such as having a large birth weight baby or needin...
....,(OTC Bullentin Board: DSCI), provider of advance...ts first quarter 2008 results before market on,Thu...rence call that same,day to discuss the results at...may also access this call via the Internet,at:, ...
Other Medicine News:Health News:UCSF receives funding for building from California stem cell agency 2Health News:UCSF receives funding for building from California stem cell agency 3Health News:UAB first in US to offer speedier precise cancer radiotherapy 2Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 2Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 3Health News:Conseco Reports First Quarter Results 2Health News:Conseco Reports First Quarter Results 3Health News:Conseco Reports First Quarter Results 4Health News:Conseco Reports First Quarter Results 5Health News:Conseco Reports First Quarter Results 6Health News:Conseco Reports First Quarter Results 7Health News:Conseco Reports First Quarter Results 8Health News:Conseco Reports First Quarter Results 9Health News:Conseco Reports First Quarter Results 10Health News:Conseco Reports First Quarter Results 11Health News:Conseco Reports First Quarter Results 12Health News:Conseco Reports First Quarter Results 13Health News:Conseco Reports First Quarter Results 14Health News:Conseco Reports First Quarter Results 15Health News:Conseco Reports First Quarter Results 16Health News:High Blood Sugar Tied to Pregnancy Complications 2Health News:High Blood Sugar Tied to Pregnancy Complications 3Health News:Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008 2
(Date:12/1/2009)... 1 RoundTable Healthcare Partners,... exclusively on the health-care industry, announce...ement to sell one of its portfolio companies, Asce...oration ("Stryker"), one of the world,s leading me...sh. Prior to closing, Ascent will distribute $35 ...
(Date:12/1/2009)...ercent radiation reduction in cardiac CT scans ,...James Earls, a radiologist from Fairfax Radiologic...resent the findings of a study that shows a 90 per...tients received from CT scans compared to scans pe...ent the study to the annual meeting of the Radiolo...
(Date:12/1/2009)... 1 CeloNova BioSciences, Inc., a p...l devices and of specialty implants, today announc...mas A. Gordy, will give an opening address for the...cular Interventions Conference in Tel Aviv, Israel...ehind and focus the rich intellectual resources of...
Breaking Medicine Technology:RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation 2Radiation Reduction in Heart CT Scans Reported in Study 2CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study 13550 1Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study 13550 2PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 1PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 2PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 3PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 4PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 5PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 6PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 7PharmAthene Reports Second Quarter 2009 Financial and Operational Results 13548 8MRI May Not Improve Breast Cancer Outcome 54414 1
...)--Apr 19, 2007 - Abraxis BioScience,Inc. (NASDAQ...mpany, announced results from two pre-clinical stu...ein acidic and rich in,cysteine) expression in can...M)) tumor-targeting technology at the 98th,America...eting held,April 14-18, 2007 in Los Angeles., "Bot...
...INESS WIRE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) t...andomized, double-blind, placebo-controlled, multi...fa) in 600 previously untreated,patients with exte...g platinum-containing chemotherapy. The study demo...n risk of death (overall,survival Aranesp compared...
Other Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7
MOST Options Systems - Straight Smooth
The Natural-Hip Family - Revision/Trauma Nonporous CoCr
MARATHON Cross Linked Polyethylene Acetabular Liner
Ringloc Acetabular Liners
Medicine Products: